Gitnux/Report 2026

Biocomputing Industry Statistics

The global biological computing market reached $2.21 billion in 2025, explore the figures behind 2026 growth to $2.9 billion, company offerings, and recent platform trends.
13Statistics
26Sources
4Sections
1Visuals
14mRead
Biocomputing Industry Statistics
How this report is researched
01Editorial Scope

Before any source is gathered, an editor locks the question, what qualifies, and how the piece will be judged.

02Source Research

Search agents collect the source set and pull each data point out with its provenance attached.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 44 days

01 Industry overview

The biocomputing industry at a glance

The global biological computing market reached $2.21 billion in 2025 and is projected to grow rapidly as DNA-, cell- and protein-based systems expand into data storage, drug discovery, diagnostics and optimization.

$2.21B[1]
Market size, 2025
31.4%[1]
Forecast CAGR, 2025–2030
$4.4B[10]
Comp-bio funding, 1H 2025
$35,000[11]
CL1 system price, 2025
Market size
The global biological computing market reached $2.21 billion in 2025 and is expected to reach $2.9 billion in 2026. The market definition includes biological materials such as DNA, proteins and living cells used for data processing, storage and problem-solving.[1]
Forecast & CAGR
The market is forecast to reach $8.64 billion by 2030, representing a 31.4% CAGR from 2025 to 2030; growth from 2025 to 2026 is estimated at 31.2%. Reported drivers include energy-efficient computing, personalized medicine, DNA data storage and hybrid biological-digital systems.[1]
Market share & regions
North America was the largest regional market in 2025, while Asia-Pacific is expected to be the fastest-growing region during the forecast period. The published market coverage includes Asia-Pacific, Europe, North America, South America, the Middle East and Africa.[1]
Segmentation
The market is segmented by component into hardware and devices, consumables, software and services; by technology into DNA-, cell-, protein- and molecular-based computing; and by deployment into biocomputing-as-a-service and on-premise wet kits. Applications include data storage, drug discovery and bioinformatics, biosensing and diagnostics, and complex optimization.[1]
Key players & concentration
Named companies include Thermo Fisher Scientific, Illumina, Ginkgo Bioworks, Twist Bioscience, Oxford Nanopore Technologies, FinalSpark, Cortical Labs, Biomemory and Catalog Technologies. The market report identifies a top-10 competitor analysis but does not disclose a quantified concentration ratio or combined market share.[1]
Pricing
Cortical Labs’ CL1 biological computer was reported to retail for approximately $35,000 per unit in 2025. The system requires laboratory facilities, while the company also planned a remote cloud-based option for users without on-site equipment.[11]
Trends, drivers & challenges
Growth is linked to synthetic biology, expanding genomic datasets, DNA-based architectures, cloud biocomputing and laboratory automation. In 2025, GenBank was reported to contain approximately 34 trillion base pairs and 4.7 billion sequences, up from about 25 trillion base pairs and 3.7 billion sequences in 2024; challenges include scaling biological systems, maintaining living-cell platforms and addressing ethical concerns around neuron-based computing.[1][11]
Consumer behavior & competition
Commercial demand is concentrated among pharmaceutical and biotechnology companies, academic and research institutes, healthcare and diagnostics organizations, data-storage providers, and environmental and industrial users. In the broader computational-biology segment, 90 companies in the United States and Europe raised nearly $4.4 billion across 90 financing rounds in 1H 2025, indicating intense early-stage competition and investor interest.[1][10]
M&A
QIAGEN agreed in 2025 to acquire Parse Biosciences for approximately $225 million in upfront cash, plus potential milestone payments of up to $55 million. Parse served more than 3,000 customers in over 40 countries, and its platform supports large-scale single-cell datasets for AI-driven biology.[12]
Latest news
A notable 2025 product launch was Cortical Labs’ CL1, described as a code-deployable biological computer combining human neurons with a silicon chip. The system was released on March 2, 2025, and is intended for applications including disease modeling and drug discovery.[11]

02 Ranking

Top 7 Companies in the Biocomputing Industry

The leading companies in the biocomputing industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 18, 2026 · Next review December 18, 2026

Verdict

Illumina stands out for DNA sequencing reads used in biocomputing because its platform reads DNA-encoded data for data storage research, while Cortical Labs focuses on biological computing on silicon since its CL1 was reported at about $35,000 per unit in 2025.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in DNA sequencing platforms

    Illumina

    US

    Ranked #1 · 9.9 · DNA sequencing platforms

    Why we picked it: Its DNA sequencing platform targets biocomputing data reads used in DNA data storage and related research workflows.

  2. Leader in biological computers on silicon

    Cortical Labs

    AU

    Ranked #2 · 9.9 · Biological computers on silicon

    Why we picked it: Its CL1 pairs code-deployable biological computing with living neurons on a silicon chip, with published 2025 unit pricing.

  3. Leader in synthetic DNA synthesis

    Twist Bioscience

    US

    Ranked #3 · 9.1 · Synthetic DNA synthesis

    Why we picked it: Its focus on commercial synthetic DNA synthesis supports biocomputing and DNA data storage research by providing input DNA.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 7 companies in the biocomputing industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Illumina

DNA sequencing platforms · US

9.9
2

Cortical Labs

Biological computers on silicon · AU

9.9
3

Twist Bioscience

Synthetic DNA synthesis · US

9.1
4

FinalSpark

Remote organoid computing · CH

8.9
5

Biomemory

Integrated DNA infrastructure · FR

7.7
6

Nuclera

Desktop DNA synthesis for biocomputing, UK · GB

7.3
7

BioCompute

DNA data storage and biological infrastructure · IN

7.0

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 18, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 19). Top 7 companies in the biocomputing industry. In Biocomputing Industry Statistics. Gitnux. https://gitnux.org/biocomputing-industry-statistics/#top-companies

report visual · Comparison

Capital raised to date by private biocomputing companies

Koniku leads with $37.0M.

Koniku$37.0M
The Biological Computing Co.$25.0M
Cortical Labs$10.0M
Frontier Computing$10.0M
MaxWell Biosystems$5.0M
source-verifiedstateofthefuture.io

04 Statistics

Market Intelligence

Market intelligence quantifies the biocomputing software proxy alongside hardware, consumables, and services, anchored at $2.21 billion in 2025.

Market size and revenue in the biocomputing industry

  • $2.21 billion was the global biological computing market size in 2025; the study covers hardware and devices, consumables, software, services, DNA-, cell-, protein- and molecular-based computing, and biocomputing-as-a-service, so it is a parent-category proxy for biocomputing software.[1]

05 Statistics

Customers & Revenue

Customer and usage indicators show recurring platform activity, including 65,000 monthly reports and 90,000 daily users tied to QIAGEN Digital Insights in 2024.

Customer and user counts in the biocomputing industry

  • 9,291 registered users held access to 11 commercial bioinformatics software and database packages at the University of Pittsburgh in fiscal 2024.[2]
  • 65,000 reports were created monthly by clinical customers using QIAGEN Digital Insights in 2024, indicating recurring platform usage.[3]
  • 90,000 users gained disease insights daily through QIAGEN Digital Insights in 2024, a named bioinformatics software platform.[3]
  • 1,762 new software registrations were recorded during fiscal 2024 for 11 commercial bioinformatics software and database packages at the University of Pittsburgh.[2]

06 Statistics

Pricing & Packaging

Pricing signals in the biocomputing-adjacent software set include $1,288 per month for Illumina BioInsight Platform Professional Monthly License in November 2026, with cloud billed separately.

Price levels in the biocomputing industry

  • $1,288 per month was the published price for Illumina BioInsight Platform Professional Monthly License in November 2026; cloud compute and storage were billed separately.[4]
  • $49 per month was the published price for BioGenOvo Professional in November 2026, including web-based bioinformatics analysis tools and downloadable software.[5]
  • $49 per month per seat was the published paid entry price for Pipette Lab Premium in a three-platform bioinformatics software pricing sample observed in November 2026.[6]
  • $25 per month was the published paid entry price for Smarts.bio Pro in a three-platform bioinformatics software pricing sample observed in November 2026.[7]
  • $10,300 per year was the published price for Illumina BioInsight Platform Professional Annual License in November 2026; cloud compute and storage were billed separately.[4]

07 Statistics

Finance

Financing indicators show sustained investor activity, including $7.3 billion raised across computational-biology companies in the United States and Europe in 2024.

Funding and investment in the biocomputing industry

  • $7.3 billion was raised across computational-biology companies in 2024 in the United States and Europe; the study includes firms using computational tools for therapeutics, R&D tools and diagnostics, including software and infrastructure providers.[8]
  • 148 financing rounds were analyzed for computational-biology companies in 2024 in the United States and Europe, including the report’s Insight Platforms & Infrastructure segment covering computational infrastructure and data platforms.[8]
  • $1 million in capital had been raised by Intactis Bio since its 2024 founding, illustrating early-stage financing for a commercial biocomputing software-and-cloud-access provider.[9]

Key questions about the biocomputing industry

What is the current size of the global biological computing market in 2025?
The global biological computing market reached $2.21 billion in 2025, with coverage that includes hardware and devices, consumables, software, and services.
How fast is the biological computing market expected to grow after 2025?
The market is forecast to reach $2.9 billion in 2026, and it is expected to reach $8.64 billion by 2030. That implies a 31.4% CAGR from 2025 to 2030, with growth from 2025 to 2026 estimated at 31.2%.
Which companies lead the biocomputing industry?
Illumina stands out for DNA sequencing reads used in biocomputing because its platform reads DNA-encoded data for data storage research, while Cortical Labs focuses on biological computing on silicon since its CL1 was reported at about $35,000 per unit in 2025.
What technology shifts are driving biocomputing deployments?
Reported drivers include expanding DNA-, cell-, and protein-based systems for data storage, drug discovery, diagnostics and optimization. Growth is also linked to cloud biocomputing and laboratory automation, plus hybrid biological-digital systems.
How is the market structured in terms of product types and delivery models?
The market is segmented by component into hardware and devices, consumables, software and services. It also splits by deployment into biocomputing-as-a-service and on-premise wet kits.
What scale and activity indicators show ongoing software and platform usage in adjacent computational-biology tooling?
In 2024, 65,000 reports were created monthly by clinical customers using QIAGEN Digital Insights, and 90,000 users gained disease insights daily through QIAGEN Digital Insights. That same year, 9,291 registered users held access to 11 commercial bioinformatics software and database packages at the University of Pittsburgh.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 19). Biocomputing Industry Statistics. Gitnux. https://gitnux.org/biocomputing-industry-statistics
MLA
Samuel Norberg. "Biocomputing Industry Statistics." Gitnux, 19 Nov 2026, https://gitnux.org/biocomputing-industry-statistics.
Chicago
Samuel Norberg. 2026. "Biocomputing Industry Statistics." Gitnux. https://gitnux.org/biocomputing-industry-statistics.